Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx حسب Fengwang Xue (22245625)

"…Compared with patients with PNI ≥ 43, patients with PNI < 43 had a 118% increased risk of 30-day mortality (HR = 2.18, 95% CI = 1.28–3.81, p = 0.005) and a 96% increased risk of 90-day mortality (HR = 1.96, 95% CI = 1.20–3.19, p = 0.008). …"

Table 4_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx حسب Fengwang Xue (22245625)

"…Compared with patients with PNI ≥ 43, patients with PNI < 43 had a 118% increased risk of 30-day mortality (HR = 2.18, 95% CI = 1.28–3.81, p = 0.005) and a 96% increased risk of 90-day mortality (HR = 1.96, 95% CI = 1.20–3.19, p = 0.008). …"

RCS for all-cause mortality. حسب Sheng Chen (21971)

"…Kaplan-Meier survival analysis, Cox proportional hazard models, and restricted cubic spline regression were applied to evaluate the association between EASIX and 30- and 60-day all-cause mortality. Subgroup analyses were also performed to assess interactions with key patient characteristics.…"

Table1_The role of glucocorticoids in increasing cardiovascular risk.docx حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Image1_The role of glucocorticoids in increasing cardiovascular risk.tiff حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Image2_The role of glucocorticoids in increasing cardiovascular risk.tiff حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Table3_The role of glucocorticoids in increasing cardiovascular risk.doc حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Table2_The role of glucocorticoids in increasing cardiovascular risk.doc حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Ribosomal subunit pathways are decreased in <i>Resf1</i> knockdown cells. حسب Megan R. Majocha (18529925)

"…<p>(A) GO Pathway analysis snapshots of various ribosomal subunit pathways that are decreased in 6DT1 <i>Resf1</i> KD cells. (B) The GO Cytosolic Ribosome pathway had many (C) small and large ribosomal proteins decreased in <i>Resf1</i> KD cells. …"

Cytochrome c movement in <i>C</i>. <i>auris</i>. حسب Hammad Alam (530008)

الموضوعات:

Subject characteristics from OPD cases. حسب Radha Joshi (22411067)

الموضوعات:

Comparative Nutrition status in cases and controls. حسب Radha Joshi (22411067)

الموضوعات:

Two different <i>Hmr</i> mutations interfere differently with HMR interactome and HMR complex formation. حسب Andrea Lukacs (3752956)

Data Sheet 1_Decrease in low-density lipoprotein cholesterol is associated with an increased risk of mortality in patients with diabetes mellitus.docx حسب Yun Gi Kim (9450226)

The nsP4-Q192L and C483Y mutations decrease the 4′-FlU sensitivity of both replication and transcription. حسب Peiqi Yin (6533747)

Pairwise correlations in APP/PS1 mice are decreased in dCA1, but increased in vCA1. حسب Udaysankar Chockanathan (18510288)

PAH in CHD and nutrition status. حسب Radha Joshi (22411067)

الموضوعات:

Stratified analysis of osteoporosis and all-cause mortality (weighted). حسب Xiaoqin Qu (20923646)

Osteoporosis and all-cause mortality survival curve (weighted). حسب Xiaoqin Qu (20923646)

DataSheet_1_Higher plasma aldosterone is associated with increased risk of cardiovascular events in hypertensive patients with suspected OSA: UROSAH data.docx حسب Lin Gan (114079)

"…</p>Conclusion<p>Higher PAC was associated with increased risk of CVD and all-cause mortality in hypertensives with suspected OSA, even in the absence of primary aldosteronism (PA). …"